Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy

National Medical Journal of China

Volumn 88, Issue 7, 2008, Pages 475-479

  Zhang, Ying ^a   Ma, Hong ^a   Liu, Shi Lian ^a   Liu, Yan Xin ^a   Zheng, De Xian ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Genes; Neoplasms; Promoter regions(genetics); Therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENHANCED GREEN FLUORESCENT PROTEIN; GENOMIC DNA; PARVOVIRUS VECTOR; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BAGG ALBINO MOUSE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL ACTIVITY; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; LEUKEMIA CELL LINE; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PURIFICATION; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TUMOR CELL; TUMOR GROWTH; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; JURKAT CELLS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; TELOMERASE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 43749101603     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Y and L. Recombinant Adeno-associated virus as delivery vector for gene therapy. Stem Cells and Dev, 2004,13:133-145.
2. Hildegard B, Markus BF, Michael H. Progress in the use of adeno-associated viral vectors for gene therapy. Cells Tissues Organs, 2004,177:139-150.
3. Ma H, Liu Y, Liu S, et al. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice. Hepatology, 2005,42:1355-1363.
4. Song JS, Kim HP, Yoon WS, et al. Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line. Biosci Biotechnol Biochem, 2003,67:2344-2350.
5. Lu B, Makhija SK, Nettelbeck DM, et al. Evaluation of tumor-specific promoter activities in melanoma. Gene Ther, 2005,12: 330-338.
6. van Houdt WJ, Haviv YS, Lu B, et al. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma. J Neurosurg, 2006,104:583-592.
7. Gu J, Fang BL. Telomerase promoter-driven cancer gene therapy. Can Bio & Ther, 2003,2:s64-70.
8. Koch PE, Guo ZS, Kagawa S. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system. Mol Ther, 2001,3:278-283.
9. Akakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res, 1999,59:551-557.
10. Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Human Mol Genet, 1999,8:137-142.
11. Ma H, Liu Y, Liu S, et al. Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors. Int J Cancer, 2005,116:314-321.
12. Jacob D, Davis J, Zhang LD, et al. Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter. Cancer Gene Ther, 2005, 12:109-115.